Quoin Pharmaceuticals (QNRX) Total Non-Current Liabilities (2018 - 2026)
Quoin Pharmaceuticals' Total Non-Current Liabilities was $6.01 million in the quarter ended Jun 30, 2026, up 38.6% from $4.34 million a year earlier and up 26.7% from the prior quarter.
Powered by 
Analysis
Quoin Pharmaceuticals (QNRX) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
As of Dec 31, 2025, Total Non-Current Liabilities at Quoin Pharmaceuticals came in at $4.95 million, up 38.1% from the prior year.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of 58.0% (years ended Dec 2020 to Dec 2025).
- In earlier years, Total Non-Current Liabilities was $3.58 million in the year ended Dec 31, 2024 (unchanged), $3.58 million in the year ended Dec 31, 2023 (+22.3%), $2.93 million in the year ended Dec 31, 2022 (-36.0%) and $4.58 million in the year ended Dec 31, 2021 (+811.6%).
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Total Non-Current Liabilities in data going back to the quarter ended Jun 30, 2019.
- Compared with a year earlier, Total Non-Current Liabilities was higher in five of the last eight quarters, with growth averaging 23.9%.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was the quarter ended Dec 31, 2021 (growth of 811.6%); the worst was the quarter ended Dec 31, 2022 (a decline of 36.0%).
- Per Business Quant data, QNRX's Total Non-Current Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $4.75 million (quarter ended Mar 31, 2026), $4.95 million (quarter ended Dec 31, 2025) and $5.76 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Quoin Pharmaceuticals | 323,761.71 | -45.14 Mn | - | 4.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.59 Mn |
| Mar 31, 2026 | 3.17 Mn |
| Dec 31, 2025 | 3.22 Mn |
| Sep 30, 2025 | 5.76 Mn |
| Jun 30, 2025 | 4.34 Mn |
| Mar 31, 2025 | 4.86 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 728,817.00 |
| Mar 31, 2024 | 850,222.00 |
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 906,695.00 |
| Jun 30, 2023 | 465,106.00 |
| Dec 31, 2022 | -596,176.00 |
| Sep 30, 2022 | -2.64 Mn |
| Jun 30, 2022 | 3.69 Mn |
| Dec 31, 2021 | 4.20 Mn |
| Dec 31, 2020 | 501,984.00 |
| Jun 30, 2020 | 826,091.17 |
| Dec 31, 2019 | 823,505.61 |
API Access
Quoin Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=QNRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "QNRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=QNRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();